Prestige Consumer Healthcare
PBH
#4715
Rank
ยฃ1.65 B
Marketcap
ยฃ34.96
Share price
1.92%
Change (1 day)
-23.29%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2023 (TTM): -ยฃ1.32

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is ยฃ2.47. In 2022 the company made an earnings per share (EPS) of ยฃ3.18 an increase over its 2021 EPS that were of ยฃ2.85.

EPS history for Prestige Consumer Healthcare from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ1.32-141.42%
2022ยฃ3.1811.7%
2021ยฃ2.8513.6%
2020ยฃ2.51-651.67%
2019-ยฃ0.45-148.78%
2018ยฃ0.93-83.29%
2017ยฃ5.57437.23%
2016ยฃ1.04-34.13%
2015ยฃ1.5752.94%
2014ยฃ1.03-8.11%
2013ยฃ1.1262.64%
2012ยฃ0.694.6%
2011ยฃ0.6670.59%
2010ยฃ0.39-113.97%
2009-ยฃ2.76-621.43%
2008ยฃ0.537.69%
2007ยฃ0.491.56%
2006ยฃ0.48-681.82%
2005-ยฃ0.08326

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.06 104.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
ยฃ5.12 107.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ3.97 61.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ0.54-78.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ2.05-17.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
ยฃ3.69 49.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
ยฃ2.42-1.84%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ2.18-11.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
-ยฃ22.42-1,008.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
ยฃ0.92-62.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel